Skip to content

Modest bone loss seen in young men taking Truvada for pre-exposure prophylaxis

Kathleen Mulligan, presenting at EACS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Why is injecting equipment re-used? Drug users do their own research to find out

Dr Angella Duvnjak at IHRC 2015. Photograph © 2015 Ahmad Yusni/Harm Reduction International.

Peer workers improve drug users’ engagement with HIV care in Ukraine

Pavlo Smyrnov at IHRC 2015. Photograph © 2015 Ahmad Yusni/Harm Reduction International.

One third of people with HIV in US study are not virally suppressed on antiretroviral therapy

How do we treat the world? Experts discuss moving to universal HIV treatment

Sofosbuvir + daclatasvir demonstrates high cure rates for people with HIV and HCV co-infection

Retreat of international donors and neglect of national governments threatens harm reduction services

Dr S. Subramaniam, Malaysian Minister of Health, at IHRC 2015. Photograph © 2015 Ahmad Yusni/Harm Reduction International.

Emergency needle exchange in Indiana reduces HIV and HCV risk for people who inject drugs

US study provides 'real world' evidence about which patients with hepatitis C should be prioritised for therapy